Within IMS, three cores and one program, Core for Homeostatic Regulation, Core for Precise Measuring and Modeling, Core for Genomic Medicine and Program for Medical Innovations, collaborate to transcend the existing scientific framework and contribute to innovative medical science for the next generation.


Go to main RIKEN website for more information

Introduction of Departments

Core for Homeostatic RegulationList of Laboratories
The ultimate goal of the Core for Homeostatic Regulation is elucidating the mechanisms of onset of human diseases and creation of new scientific paradigms. This Core clarifies the regulation of homeostasis in individuals, focusing on the immune system, metabolism and neuro-endocrine and environmental response systems. In addition, the Core for Homeostatic Regulation will validate the disease models established by the Core for Precise Measuring and Modeling, in a multi-tier timeframe from before to after the onset of diseases.
Core for Precise Measuring and ModelingList of Laboratories
The Core for Precise Measuring and Modeling aims to elucidate the mechanisms of human disease onset through collection of multi-tier timeframe data to build a computational and predictive network of the process. From this perspective they will undertake a comparative review of the collected multi-tier timeframe data in experimental animals, and suggest models that will lead to discovery of mechanisms of disease onset in humans.
Core for Genomic MedicineList of Laboratories
The Core for Genomic Medicine aims to be at the forefront of personalized medicine. This Core will construct a research infrastructure to define variations in the human genome, undertake comprehensive genomic analysis to elucidate the pathogenesis and prognosis of cancer, cardiovascular diseases and diabetes, analyze drug responsiveness by combining genomic information and various environmental factors, and develop technologies for clinical translational research.
Program for Medical InnovationsList of Laboratories
The Program for Medical Innovations targets research aimed at medical application. They will implement the development of therapies for hay fever, food allergies, novel cancer treatment, and regenerative medicine for the immune system using iPS technologies.